Skip to main content
Premium Trial:

Request an Annual Quote

Metabolomics Australia Opens Melbourne Node

NEW YORK (GenomeWeb News) – Metabolomics Australia has opened the latest node in its network with the launch of its A$9.5 million ($6.3 million) center in Victoria at the University of Melbourne, the university said today.
 
The new facility will offer metabolomics services to researchers in academia and in industry studying medicine, agriculture, and the environment.
 
The Melbourne branch will focus on discovering biomarkers for disease, drug responsiveness, health and fitness, agriculturally important crop plant characteristics, and environmental stress response. The center will also assess the chemical profiles of patients and organisms in response to disease, genetic variation, or therapeutic treatments.
 
“With the help of powerful computing and improved software it will be possible to map metabolites onto known metabolic pathways and also identify novel pathways and networks of responses that will lead to the identification of the function of proteins/genes as well as the discovery of new biomarkers,” said Tony Bacic, platform convener for the Victorian node, in a statement.
 
The National Collaborative Research Infrastructure Strategy provided A$5.3 million for the center, the Victorian government provided A$2.7 million, and the University of Melbourne is pitching in A$1.65 million.
 
Now complete, MA also has network nodes in Queensland at the University of Queensland, in South Australia at the Australian Wine Research Institute, and in Western Australia at the University of Western Australia and Murdoch University.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more